Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with ADT and Radiotherapy in Localized Prostate Cancer
NCT00924807Phase 2Terminated
- Sponsor
- Mount Sinai Beth Israel
- Start
- Sep 2008
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in prostate cancer (PCa), sponsored by Mount Sinai Beth Israel. Started Sep 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00924807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924807.